A clinical trial of a new flu medication will begin Monday at Holy Name Medical Center, northjersey.com reports.
Participants in the trial will be given a placebo or the drug, manufactured by Fugifilm Pharmaceuticals, the report said. Anyone involved in the study will need to be at the medical center's research facility for six days in a row and undergo basic medical tests.
Participants with flu or flu symptoms must be between 18 to 80 years old without underlying health conditions.
Holy Name is one of 70 sites across the country participating in the Phase 2 trial, which is overseen by the Department of Defense, according to the report.
For more information, call 201-541-6315.